BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37384714)

  • 1. Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples.
    Lakhal-Naouar I; Hack HR; Moradel E; Jarra A; Grove HL; Ismael RM; Padilla S; Coleman D; Ouellette J; Darden J; Storme C; Peachman KK; Hall TL; Huhtanen ME; Scott PT; Hakre S; Jagodzinski LL; Peel SA
    PLoS One; 2023; 18(6):e0287576. PubMed ID: 37384714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantification.
    Scutari R; Renica S; Cento V; Nava A; Sammartino JC; Ferrari A; Pani A; Merli M; Fanti D; Vismara C; Scaglione F; Puoti M; Bandera A; Gori A; Piralla A; Baldanti F; Perno CF; Alteri C
    PLoS One; 2023; 18(9):e0291120. PubMed ID: 37656746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.
    Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Jun; 127():104383. PubMed ID: 32353760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of Analytical and Clinical Sensitivity of Aptima SARS-CoV-2 Assay (Hologic) and Proposals of Complementary Tests for SARS-CoV-2 Detection in Low Viral Load Specimens.
    La MV; Koo SH; Jiang B; Heng YX; Tan TY
    Curr Microbiol; 2021 Dec; 79(1):29. PubMed ID: 34905087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples.
    Deming ME; Dong TQ; Agrawal V; Mills MG; Huang MLW; Greninger AL; Jerome KR; Wener MH; Paasche-Orlow MK; Kissinger P; Luk A; Hoffman RM; Stewart J; Kottkamp AC; Bershteyn A; Chu HY; Stankiewicz Karita HC; Johnston CM; Wald A; Barnabas R; Brown ER; Neuzil KM
    J Infect Dis; 2022 Sep; 226(5):788-796. PubMed ID: 35150571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
    Santos Bravo M; Nicolás D; Berengua C; Fernandez M; Hurtado JC; Tortajada M; Barroso S; Vilella A; Mosquera MM; Vila J; Marcos MA
    J Infect Dis; 2021 Oct; 224(8):1325-1332. PubMed ID: 34329473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A culture-free method for rapidly and accurately quantifying active SARS-CoV-2.
    Yang Y; Feng X; Pan Y; Wang X; Peng T; Niu C; Qu W; Zou Q; Dong L; Dai X; Li M; Fang X
    Anal Bioanal Chem; 2023 Sep; 415(23):5745-5753. PubMed ID: 37486370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of performance between three SARS-CoV-2 molecular assays (Aptima™, Laboratory Developed Test-Fusion, and R-GENE®) with special attention to turnaround time, a key point in laboratory management.
    Lefeuvre C; Pivert A; Przyrowski E; Bouthry E; Darviot E; Mahieu R; Lunel-Fabiani F; Ducancelle A; Le Guillou-Guillemette H
    J Med Virol; 2022 Jul; 94(7):3399-3403. PubMed ID: 35211992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Commercially Available and Laboratory-Developed Assays for
    Lieberman JA; Pepper G; Naccache SN; Huang ML; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32350048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Panther Fusion System with Open Access Functionality for Laboratory-Developed Tests for Influenza A Virus Subtyping.
    Stellrecht KA; Cimino JL; Maceira VP
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity.
    Berg MG; Zhen W; Lucic D; Degli-Angeli EJ; Anderson M; Forberg K; Olivo A; Sheikh F; Toolsie D; Greninger AL; Cloherty GA; Coombs RW; Berry GJ
    J Clin Virol; 2021 Oct; 143():104945. PubMed ID: 34450558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand.
    Basu I; Nagappan R; Fox-Lewis S; Muttaiyah S; McAuliffe G
    J Virol Methods; 2021 Mar; 289():114042. PubMed ID: 33345831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.
    Hogan CA; Garamani N; Lee AS; Tung JK; Sahoo MK; Huang C; Stevens B; Zehnder J; Pinsky BA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32461285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System.
    Grant J; Atapattu N; Dilcher M; Tan CE; Elvy J; Ussher JE
    J Clin Virol; 2023 Feb; 159():105355. PubMed ID: 36603330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a laboratory-developed test for simultaneous detection of norovirus and rotavirus by real-time RT-PCR on the Panther Fusion® system.
    Kulis-Horn RK; Tiemann C
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):103-112. PubMed ID: 31506730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting.
    Osborn LJ; Chen PY; Flores-Vazquez J; Mestas J; Salas E; Glucoft M; Smit MA; Costales C; Dien Bard J
    J Clin Virol; 2023 Jul; 164():105494. PubMed ID: 37210881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay.
    Perchetti GA; Pepper G; Shrestha L; LaTurner K; Yae Kim D; Huang ML; Jerome KR; Greninger AL
    J Clin Virol; 2021 Jul; 140():104869. PubMed ID: 34023572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction.
    Hwang HS; Lo CM; Murphy M; Grudda T; Gallagher N; Luo CH; Robinson ML; Mirza A; Conte M; Conte A; Zhou R; Vergara C; Brooke CB; Pekosz A; Mostafa HH; Manabe YC; Thio CL; Balagopal A
    J Infect Dis; 2023 Apr; 227(8):981-992. PubMed ID: 36468309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus.
    Roesmann F; Jakobsche I; Pallas C; Wilhelm A; Raffel J; Kohmer N; Toptan T; Berger A; Goetsch U; Ciesek S; Widera M
    J Clin Virol; 2023 Aug; 165():105499. PubMed ID: 37327554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system.
    Stevens BA; Hogan CA; Mfuh KO; Khan G; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
    J Clin Virol; 2021 May; 138():104792. PubMed ID: 33770659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.